LAUREN IMBRIANI: Open Payments
NPI 1649905837 · ORADELL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,242 in 80 payments from 14 companies in 2025. Trend: 2023 $398 · 2024 $797 · 2025 $1,242
Food & beverage: $1,242
| Company | Payments | Amount |
|---|---|---|
| Almatica Pharma LLC | 12 | $194 |
| Supernus Pharmaceuticals, Inc. | 12 | $174 |
| Tris Pharma Inc | 11 | $156 |
| ABBVIE INC. | 11 | $154 |
| Axsome Therapeutics, Inc. | 7 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $100 |
| Vanda Pharmaceuticals Inc. | 5 | $81 |
| Otsuka America Pharmaceutical, Inc. | 4 | $64 |
| Alkermes, Inc. | 3 | $52 |
| Corium, LLC | 3 | $45 |
Products named: LOREEV XR, Qelbree, Dyanavel XR, VRAYLAR, Auvelity, TRINTELLIX, REXULTI, FANAPT.
Industry payments across NJ — which companies pay providers there.
